phase readout
saveNCT06598306: Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
RECRUITINGupdated 22h ago
community read0 votes
Sponsor: Amgen. Phase: PHASE1. Conditions: Extensive Stage Small Cell Lung Cancer
view source ↗
comments(0)
5-min edit window · permanent after that